Voxelotor Patent Expiration

Voxelotor is Used for increasing hemoglobin levels and treating sickle cell disease by administering Voxelotor orally to patients. It was first introduced by Global Blood Therapeutics Inc in its drug Oxbryta on Nov 25, 2019.


Voxelotor Patents

Given below is the list of patents protecting Voxelotor, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Oxbryta US10493035 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Oct 12, 2037 Global Blood Theraps
Oxbryta US11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Dec 02, 2036 Global Blood Theraps
Oxbryta US11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Dec 02, 2036 Global Blood Theraps
Oxbryta US10722502 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Feb 06, 2035 Global Blood Theraps
Oxbryta US11452720 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Feb 06, 2035 Global Blood Theraps
Oxbryta US9447071 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde Feb 06, 2035 Global Blood Theraps
Oxbryta US9248199 1:1 adducts of sickle hemoglobin Jan 29, 2034 Global Blood Theraps
Oxbryta US9018210 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation Nov 25, 2033 Global Blood Theraps
Oxbryta US10017491 Compounds and uses thereof for the modulation of hemoglobin Dec 28, 2032 Global Blood Theraps
Oxbryta US10034879 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation Dec 28, 2032 Global Blood Theraps
Oxbryta US10806733 Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation Dec 28, 2032 Global Blood Theraps



Voxelotor's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List